Delivery Order SPE2DR25D3303-SPE2DR26F65H2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $68,803.32 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count packages) on December 16, 2025, with completion scheduled for December 17, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $18,398.35 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a completion date of September 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement conducted under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,494.29 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count package), with an ultimate completion date of November 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a delivery order valued at $7,178.56 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count), with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and will be performed at the company's corporate office in Conshohocken, Pennsylvania. Trelegy Ellipta is a prescription maintenance inhaler used to treat chronic obstructive pulmonary...
- The Defense Logistics Agency awarded a delivery order valued at $2,284.27 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on July 28, 2025, with completion targeted for July 29, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used to treat chronic obstructive...
- The Defense Logistics Agency awarded a delivery order valued at $2,059.98 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count supply). This firm fixed price, non-competitive delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination pharmaceutical product used in respiratory disease management,...
- The Defense Logistics Agency awarded a delivery order valued at $12,543.10 to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count package). This firm fixed price, non-competitive delivery order is scheduled for completion by January 6, 2026, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination inhaler containing fluticasone, umeclidinium, and vilanterol,...
- The Defense Logistics Agency awarded a delivery order valued at $5,333.07 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on November 17, 2025, with completion expected by November 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,006.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on September 23, 2025, with an ultimate completion date of September 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination respiratory medication used for chronic...
- The Defense Logistics Agency awarded a delivery order valued at $4,415.80 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination maintenance inhaler used for chronic obstructive pulmonary...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65H2Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,780.61 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This competitive award, made without set-aside designation, is issued under an Indefinite Delivery Contract with DLA Troop Support Medical (contract value up to $999,999,999.00 through December 2026). Trelegy Ellipta is a combination respiratory maintenance medication used for treating chronic obstructive pulmonary disease, reflecting the Defense Logistics Agency's critical role in supplying pharmaceutical products to military healthcare systems worldwide. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a subsidiary of Cencora, Inc. (which does business as AmerisourceBergen). The company maintains a significant portfolio of federal contracts with the Defense Logistics Agency and other government agencies, supplying an extensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order exemplifies the company's role as a critical vendor supporting military and federal healthcare procurement through competitively awarded firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 1/8/26 |